{"entity":{"type":"insider","cik":"0001990829","url":"/insider/0001990829","json_url":"/insider/0001990829.json","name":"Corvus Capital Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":1,"first":"2024-09-19","last":"2024-09-19","span_basis":"filed_date"},"name_variants":[{"name":"Corvus Capital Ltd.","source":"filing","n_filings":1,"first_seen":"2024-09-19","last_seen":"2024-09-19"}],"transactions":[{"id":2090519,"accession":"0001493152-24-037150","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-12","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1514100.0,"shares_display":"1,514,100","price_per_share":0.2583,"price_display":"0.26","price_state":"stated","total_value":391092.03,"total_display":"391,092.03","total_whole":"391,092","shares_owned_after":177627.0,"shares_owned_after_display":"177,627","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-09-19","scope":"insider"},{"id":2090516,"accession":"0001493152-24-037150","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-11","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10244392.0,"shares_display":"10,244,392","price_per_share":0.3169,"price_display":"0.32","price_state":"stated","total_value":3246447.8248,"total_display":"3,246,447.82","total_whole":"3,246,448","shares_owned_after":1691727.0,"shares_owned_after_display":"1,691,727","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-09-19","scope":"insider"},{"id":2090511,"accession":"0001493152-24-037150","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-10","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1005200.0,"shares_display":"1,005,200","price_per_share":0.2471,"price_display":"0.25","price_state":"stated","total_value":248384.92,"total_display":"248,384.92","total_whole":"248,385","shares_owned_after":11936119.0,"shares_owned_after_display":"11,936,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-09-19","scope":"insider"},{"id":2090509,"accession":"0001493152-24-037150","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-9","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1389820.0,"shares_display":"1,389,820","price_per_share":0.2471,"price_display":"0.25","price_state":"stated","total_value":343424.522,"total_display":"343,424.52","total_whole":"343,425","shares_owned_after":12941319.0,"shares_owned_after_display":"12,941,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-12","filed_date":"2024-09-19","scope":"insider"},{"id":2090505,"accession":"0001493152-24-037150","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":882952.0,"shares_display":"882,952","price_per_share":0.29475366090115884,"price_display":"0.29","price_state":"stated","total_value":260253.3344,"total_display":"260,253.33","total_whole":"260,253","shares_owned_after":14631139.0,"shares_owned_after_display":"14,631,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-09-19","scope":"insider","n_lines":2},{"id":2090499,"accession":"0001493152-24-037150","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-6","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":0.3338,"price_display":"0.33","price_state":"stated","total_value":50070.0,"total_display":"50,070.00","total_whole":"50,070","shares_owned_after":15214091.0,"shares_owned_after_display":"15,214,091","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-09-19","scope":"insider"},{"id":2090495,"accession":"0001493152-24-037150","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-5","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77681.0,"shares_display":"77,681","price_per_share":0.4358,"price_display":"0.44","price_state":"stated","total_value":33853.3798,"total_display":"33,853.38","total_whole":"33,853","shares_owned_after":15364091.0,"shares_owned_after_display":"15,364,091","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-09-19","scope":"insider"},{"id":2090492,"accession":"0001493152-24-037150","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-4","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35923.0,"shares_display":"35,923","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":18320.73,"total_display":"18,320.73","total_whole":"18,321","shares_owned_after":15441772.0,"shares_owned_after_display":"15,441,772","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-08","filed_date":"2024-09-19","scope":"insider"},{"id":2090488,"accession":"0001493152-24-037150","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-24-037150","line_url":"/filing/0001493152-24-037150#line-3","is_derivative":false,"issuer_cik":"0001896212","issuer_name":"CONDUIT PHARMACEUTICALS INC.","issuer_ticker":"CDT","issuer_name_source":null,"issuer_url":"/issuer/0001896212","owner_cik":null,"owner_name":"Algo Holdings, Inc.; Corvus Capital Ltd.; Regan Andrew","owner_display_name":"Algo Holdings, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":640.0,"total_display":"640.00","total_whole":"640","shares_owned_after":15477695.0,"shares_owned_after_display":"15,477,695","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-09-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001896212","name":"CONDUIT PHARMACEUTICALS INC.","url":"/issuer/0001896212","role":"Ten percent owner","n_filings":1,"first_seen":"2024-09-19","last_seen":"2024-09-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001990829","retrieved_at":"2026-08-23T05:29:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}